{"id":"W1978824248","doi":"10.1038/jid.2011.304","title":"A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis","year":2011,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":166,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Abbott Laboratories","keywords":"Placebo; Medicine; Adverse effect; Psoriasis; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Gastroenterology; Surgery; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196943,0.0003756193,0.003146605,0.0004859288,0.0001722718,0.00001087848,0.0005572629,0.0004138018,0.0003288938],"category_scores_gemma":[0.001098415,0.0002271397,0.000877009,0.0002845751,0.0009945093,0.0001511975,0.00009768925,0.0004817064,0.00003154598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007130175,"about_ca_system_score_gemma":0.000434263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009353877,"about_ca_topic_score_gemma":0.0001087224,"domain_scores_codex":[0.9938132,0.003236365,0.002148505,0.0002627225,0.0001183318,0.0004209253],"domain_scores_gemma":[0.9964658,0.0007496401,0.002024945,0.0003328643,0.0003419947,0.00008473151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9359963,0.001264621,0.0001808171,0.00001477453,0.002316178,0.0001211402,0.007383345,0.000009576243,0.04764218,0.00356623,0.001156103,0.0003487486],"study_design_scores_gemma":[0.7871357,0.000842182,0.0002210768,0.00008769107,0.0006787716,0.00076036,0.0004652901,0.000005355296,0.2045458,0.004968978,0.0001112793,0.0001774878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932631,0.0006418382,0.00006261695,0.0006115189,0.001574135,0.002168069,0.0000331878,0.0000119029,0.001633603],"genre_scores_gemma":[0.9986855,0.00004297451,0.0002897431,0.0003469723,0.00007224132,0.0001739694,0.000008933197,0.00002199574,0.000357671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1569036,"threshold_uncertainty_score":0.9262488,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03313375104487552,"score_gpt":0.267880182342678,"score_spread":0.2347464312978025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}